Sign In
NewsRadar

DelfMEMS

DelfMEMS is focused on radio-frequency micro electro mechanical systems (RF MEMS) switching technology.

The company aims to deliver high performance solutions for small-signal switching applications. It provides an efficient low voltage RF MEMS switching technology that is said to enable stand-alone components, high performances, high lifetime and hot switching operations.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Haute Borne, 5 rue Heloise
Villeneuve d'Ascq 59650
France
(+33) 9 754 639 16
(+33) 3 208 444 38
http://www.delfmems.com
Olivier Millet
(+33) 9 754 639 16

Company Facts
Founded:Dec 2005
Founders:Olivier MILLET
CEO:Guillaume d’Eyssautier
CTO or technical lead:KArim Segueni
CFO or finance director:Cybele Rolland
Head of Sales:Alex Schops
Head of Marketing:Olivier Millet

Stage:Early Stage
Category:Materials & Nanotechnology
Sector:MEMS
Employees:15
Profitability:Not Profitable
Funding raised:Yes
Funding sought:Yes
Seeking Partnerships:Yes

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


20,020
Tech investments
From our Online Data Service
12,902
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
May 27€0.6MInternet services
May 26€1.0MBusiness applications
May 26€1.5MBusiness applications
May 26€1.1MBiopharmaceuticals
May 22N/AInternet services
May 22N/AInternet commerce
May 22€2.0MWireless hardware

For information on Europe's most extensive database on technology funding click here!

Events


EVCA CFO Forum
June 2 - 3, 2015

BIO-Europe 2015
November 2 - 4, 2015

CONNECTIONS Europe
November 10 - 11, 2015


Press Releases


May 28
Trustpilot
trustpilot closes $73.5 million series d round, becomes the standar...

May 26
Conor Venture Partners Oy
conor leads 50 mdkk investment round to blackwood seven

May 22
Cristal Therapeutics (formerly Cristal Delivery)
cristal therapeutics announces formation of scientific advisory board

May 21
Isarna Therapeutics (formerly Antisense Pharma)
isarna announces orphan drug designation in the european union for...

May 20
Kobojo
independent game developer kobojo closes $7m round series b funding...





About usContact usLegal Information
Copyright 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.